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The aim of this investigation was to analyze metabolic
syndrome (MS) impact on carotid intima-media thickness
(cIMT). Prospective study of 300 patients with suspected
coronary artery disease admitted for an elective coronary
angiography were evaluated. Patients with previously
known cardiac disease were excluded. In the population,
23.0% were diabetics and 40.5% had MS (but no diabe-
tes). cIMT was not significantly different in patients with
MS, but was significantly higher in diabetic patients
compared with MS and control patients. Independent
predictors of cIMT were age, male gender, insulin, and
high-density lipoprotein (HDL) cholesterol (the last one with
an inverse association). In patients without MS, only age
and HDL cholesterol were associated. In patients with MS,
independent predictors were age, male gender, and
glucose, and abdominal obesity showed an inverse
relationship. In patients with stable angina, MS is not an
independent predictor of cIMT. Nonmodifiable variables
(age and gender) are the most important determinants of
cIMT, as well as blood glucose, in MS patients. Abdominal
obesity was protective. J Clin Hypertens (Greenwich).
2012; 14:507–513. 2012 Wiley Periodicals, Inc.
Cardiovascular disease (CVD) is one of the leading
causes of death in developed countries and is increas-
ing, along with obesity.1–3 CVD is a major problem in
Portugal, not only as far as ischemic heart disease is
concerned, but also in terms of stroke, the incidence
of which is among the highest in the world. In fact, in
developed countries, the most common CVD is ische-
mic heart disease, which is also the leading cause of
death in the European Union with the exception of
Greece, the former Yugoslavia Republic of Macedonia,
and Portugal, where it is stroke.4 Clinically, it is of
great significance to identify patients at risk for devel-
oping stroke and other cardiovascular events to enable
preventive interventions and promote lifestyle modifi-
cations. Carotid intima-media thickness (cIMT) has
been suggested as a surrogate marker for coronary and
peripheral artery disease, because it is easily obtained
by a noninvasive test and is therefore recommended by
guidelines for cardiovascular risk stratification, partic-
ularly in patients at intermediate-risk.5–8 Both cIMT
and total carotid plaque area are associated with
future risk of ischemic strokes and myocardial infarc-
tion.6,9–12 With the obesity epidemic, metabolic
syndrome (MS) prevalence is also increasing and it is
also an independent predictor of cardiovascular
events.2,3,13,14 Most studies in primary prevention
settings showed a relationship between MS and
cIMT.15–17 However, in patients with stable angina,
this association is less studied.
Our aim was to identify the predictors of cMIT and
to analyze whether there is an association between MS
and cIMT in a population of patients admitted for
coronary angiography due to suspicion of coronary
artery disease and without previous history of heart
disease. We also compared patients with MS with
those with diabetes (in whom the association with
arterial disease is more clear and for some authors is
responsible for the MS impact on cardiovascular
outcomes) and with a control group with neither
diagnosis (‘‘normal’’).
MATERIALS AND METHODS
The present study is an observational and cross-
sectional study, with prospective inclusion of patients
admitted for elective coronary angiography with sus-
pected coronary artery disease (with stable angina
and ⁄or with documented ischemia on noninvasive
tests). All patients were 18 years and older. Patients
with previous acute coronary syndrome, myocardial
revascularization procedure, valvular heart disease,
congenital heart disease, or cardiomyopathy were
excluded from the study. All patients gave their writ-
ten informed consent and the study protocol conforms
to the ethical guidelines of the 1975 Declaration of
Helsinki as reflected in a priori approval by the local
institutional ethics committee. Significant angiographic
coronary artery disease was defined as stenosis of
50% in any coronary vessel.
Anthropometrical data were obtained after a 12-
hour fast, with the patient in light clothing and bare-
foot. Body weight was measured to the nearest 1 kg
using a digital scale, and height to the nearest centime-
ter in the standing position. Body mass index (BMI)
was calculated as weight in kilograms divided by
height in meters squared. Waist circumference was
measured to the nearest centimeter, with the patient
standing, using a flexible and nondistensible tape mid-
way between the lower limit of the rib cage and the
iliac crest.
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Blood pressure (BP) was measured on several occa-
sions during the hospital stay and hypertension was
defined by a previous diagnosis of hypertension or the
presence of systolic BP 140 mm Hg or diastolic BP
90 mm Hg (mean of two consecutive measurements).
Patients who smoked during the previous 6 months
were classified as smokers and were self-reported.
A venous blood sample was drawn after a 12-hour
overnight fast. All the samples were analyzed at the
central laboratory of the hospital. Levels of serum
glucose, total cholesterol, and triglycerides were
determined using automatic standard routine enzy-
matic methods. High-density lipoprotein (HDL)
cholesterol was determined after specific precipitation
and low-density lipoprotein (LDL) cholesterol was
determined by Friedwald formula. Blood insulin was
determined by electrochemiluminescence.
MS was defined by the most recent definition from
the American Heart Association ⁄National Heart, Lung
and Blood Institute (AHA ⁄NHLBI) in which patients
had to fulfill 3 of the following criteria: fasting
glucose 100 mg ⁄dL or antidiabetic treatment; BP
130 ⁄85 mm Hg or antihypertensive medication;
triglycerides 150 mg ⁄dL or specific treatment for this
lipid abnormality; HDL cholesterol <50 mg ⁄dL in
women and <40 mg ⁄dL in men or specific treatment
for this lipid abnormality; and waist circumference
88 cm in women and 102 cm in men.18 Diabetes
was recorded by the investigator by patient history,
increased glucose (fasting level 126 mg ⁄dL), or con-
comitant use of specific therapies.
The carotid ultrasound procedure was performed
with a Siemens Sonolite system (Siemens, Munich,
Germany) and a 7.5-MHz linear array transducer. The
cIMT was measured by a trained radiologist (blinded
to risk factor history) at the distal common carotid
artery (CCA) (1 cm proximal to dilation of the carotid
bulb) at the far wall. The higher yield and superior
reproducibility of measurement of the CCA IMT com-
pared with internal carotid artery (ICA) and bulb IMT
favors its use in the IMT measurements, and this was
the segment chosen for the study. Manual measure-
ments were taken from both the right and the left side.
The final cIMT obtained was the maximum cIMT
between both sides. Carotid plaque was defined as a
focal structure encroaching into the arterial lumen
with a thickness >50% of the surrounding IMT or
>1.5 mm. The interclass correlation coefficients for
intra-reader and inter-reader reproducibility of cIMT
were 0.907 and 0.820, respectively, which suggests
good agreement beyond chance.
Statistical Analysis
Statistical analysis was conducted using the PASW
18.0 program (SPSS Inc, Chicago, IL). A P value <.05
was considered statistically significant. Quantitative
variables were expressed as meanstandard deviation
(or median and interquartile range if not normally
distributed) and qualitative variables as percentages.
Student t test was used for between-group compari-
sons of continuous variables as well as one-way analy-
sis of variance test when comparing more than two
groups, while chi-square test was used for between-
group comparisons of categoric variables. Some con-
tinuous variables were highly skewed and we per-
formed a 10-based logarithmic transformation (Log)
that was used in the subsequent analysis. Blood glu-
cose required a natural logarithmic transformation
(Ln) to improve normality. Pearson’s correlation was
done between continuous variables and cIMT. Simple
and multiple backward linear regression analysis (with
cIMT as the outcome variable) were performed to
determine the independent predictors of cIMT.
RESULTS
We included 300 patients in the study, 59% men, with
a mean age of 649 years (aged 38–86 years).
Patient’s characteristics are described in Table I. In
the general population, 79% had a systolic BP
<135 mm Hg and 83% a diastolic BP <85 mm Hg,
52% had LDL cholesterol <115 mg ⁄dL, 78% had
triglycerides <150 mg ⁄dL, 52% had normal HDL
cholesterol, and 78% had a glycated hemoglobin
7.0%. In the group with diabetes, 56% had sys-
tolic BP <130 mm Hg and 65% had diastolic BP
<80 mm Hg, 11% had LDL cholesterol <70 mg ⁄dL,
78% had triglycerides <150 mg ⁄dL, 58% had normal
HDL cholesterol, and 33% had a glycated hemoglobin
7.0%. Significant angiographic coronary artery dis-
ease was present in 51.3% of patients. Mean cIMT
was 0.880.33 mm, significantly higher in men
(0.940.35 mm vs 0.810.29 mm, P=.001). Carotid
















Glucose, mg ⁄ dL 100 (92–115)
Insulin, lU ⁄ mL 8.6 (5.7–13.6)
Total cholesterol, mg ⁄ dL 181 (155–213)
HDL cholesterol, mg ⁄ dL 43 (36–54)
LDL cholesterol, mg ⁄ dL 114 (93–136)
Triglycerides, mg ⁄ dL 97 (68–134)
Abbreviations: HDL, high-density lipoprotein; LDL, low-density lipo-
protein; SD, standard deviation; IQR, interquartile range.
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plaques were present in 6.0% of patients, also slightly
higher in men (7.9% vs 3.3%, P=.155). Only 4
patients had hemodynamically significant stenosis
(>70%) in the carotid tree. cIMT increased with age
(Table II) and was also higher in men in both groups
with age lower than 65 years (0.870.35 mm vs
0.760.29 mm, P=.037) and with an age 65 years or
older (1.000.33 mm vs 0.870.35 mm, P=.009).
MS prevalence by the AHA ⁄NHLBI definition in the
present population was 55.3%. Hypertensive and dia-
betic patients had an increased cIMT and patients with
low HDL cholesterol showed a trend toward increased
cIMT (Table III). MS was not associated with cIMT,
although, when separated by gender, it showed a trend
to be higher in male patients with MS (Table IV). No
association was found with carotid plaques.
In the entire population, the prevalence of diabetes
was 23.0% and MS (nondiabetic) was 40.5%; 36.7%
had neither diagnosis. In the control group, cIMT was
0.850.34, 0.880.31 mm in the MS group and
0.970.34 mm in the diabetes group (P=.007). Signifi-
cant differences were found between the normal group
and diabetics (P=.002) and between MS patients and
diabetic (P=.025). No difference was found between
the normal group and the MS group cIMT (P=.223).
After inclusion of diabetic patients with MS in the MS
group, the new values obtained for cIMT were
0.900.33 mm for the MS group and 0.960.25 mm
for the remaining diabetics. There was a significant
difference between normal patients and diabetics
(P=.016) and a trend between normal and MS patients
(P=.055). Measurements were identical between MS
patients and diabetics (P=.159).
cIMT correlated positively with age, blood glucose,
triglycerides, and insulin, as well as with male gender,
hypertension, and diabetes and it correlated inversely
with HDL cholesterol, but these associations were
mainly found in the subset of patients with MS
(Tables V and VI). In patients without MS, cIMT cor-
related only with age (positively) and HDL cholesterol
(inversely). MS was not a predictor of cIMT (r=0.056,
P=.331); however, the number of aggregated compo-
nents was associated with cIMT (r=0.118, P=.042),
although this relationship is not linear.
Risk factors for coronary artery disease explained
only 11.4% of cIMT variance. In the overall popula-
tion, the independent predictors of cIMT were age,









cIMT, mm 0.720.15 0.850.35 0.930.34 0.980.26 .003
Plaques, % 0 4.8 9.3 4.5 .243
Abbreviation: cIMT, carotid intima-media thickness.
TABLE III. cIMT for Each Cardiovascular Risk Factor
Risk Factor Present Absent P Value
Hypertension 0.900.34 0.780.26 .026
Diabetes 0.970.33 0.860.32 .017
Smoking 0.930.27 0.880.33 .446
Increased WC 0.870.29 0.910.38 .296
Low HDL cholesterol 0.920.36 0.850.29 .058
Increased triglycerides 0.930.36 0.880.32 .260
Increased glucose 0.910.33 0.860.32 .122
Male gender 0.940.35 0.810.29 .001
Abbreviations: cIMT, carotid intima-media thickness; HDL, high-
density lipoprotein; WC, waist circumference.
TABLE IV. Carotid Findings in Patients With
Metabolic Syndrome and by Gender
Total
Metabolic syndrome
Yes No P Value
Total
cIMT, mm 0.890.33 0.900.33 0.870.33 .331
Plaques, % 6.0 6.0 6.0 1.000
Men
cIMT, mm 0.940.35 0.990.36 0.900.33 .077
Plaques, % 7.9 9.6 6.4 .602
Women
cIMT, mm 0.810.29 0.820.28 0.800.32 .713
Plaques, % 3.3 2.4 5.0 .829
Abbreviation: cIMT, carotid intima-media thickness.








R P Value R P Value R P Value
Age 0.229 <0.001 0.215 0.006 0.235 .006
Waist
circumference
0.057 0.328 )0.029 0.712 0.128 .139
BMI 0.053 0.360 )0.027 0.729 0.126 .146
Ln-Glucose 0.145 0.012 0.203 0.009 0.055 .531
Log-Triglycerides 0.128 0.027 0.154 0.048 0.065 .454
Log–HDL
cholesterol
)0.219 <0.001 )0.236 0.002 )0.185 .033
Log-LDL
cholesterol
0.007 0.907 0.047 0.550 )0.038 .660
Log–Non-HDL
cholesterol
0.032 0.585 0.066 0.397 )0.018 0.832
Log-Total
cholesterol
0.044 0.452 )0.004 0.956 )0.087 .317
Log-Insulin 0.172 0.003 0.204 0.008 0.109 .210
Abbreviations: BMI, body mass index; cIMT, carotid intima-media
thickness; MS, metabolic syndrome.
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male gender, insulin, and HDL cholesterol (the last
one inversely) (Table VII). By multivariate analysis in
patients without MS, we found that age (b=0.224,
P=.008) and LogHDL cholesterol (b=)0.170, P=.045)
were the only variables independently associated with
cIMT. In patients with MS, independently associated
variables were age (b=0.210, P=.004), male gender
(b=0.185, P=.015), Ln-glucose (b=0.177, P=.015), and
increased waist circumference (b=)0.164, P=.031).
DISCUSSION
Our results confirmed the previously described associa-
tion between cIMT and age (related to ‘‘vascular age’’)
as well as with gender. The slight increase in cIMT in
MS patients is mainly driven by diabetes, since no
difference was found between normal patients’ and
nondiabetic MS patients’ cIMT. Risk factors that are
more associated with cIMT are age, hypertension,
diabetes, male gender, HDL cholesterol, triglycerides,
glucose, and insulin. However, after multivariate anal-
ysis, only age, gender, HDL cholesterol, and insulin
remained independently associated with cIMT. But a
different result is obtained accordingly to metabolic
status. In patients without MS, only age and HDL
cholesterol predicted cIMT. In MS patients, predictors
were age, male gender, glucose, triglycerides, and
abdominal obesity (the last one with an inverse rela-
tionship).
Previously published prospective studies on cIMT
and CVD risk demonstrated that cIMT was signifi-
cantly associated with risk for myocardial infarction,
stroke, coronary heart disease death, or a combination
of these.5,6,9,19–24 cIMT value also adds additional
information beyond traditional risk factors for classify-
ing patients in regard to the likelihood of presence of
significant angiographic coronary artery disease.25,26
These findings provide support to the concept that
cIMT measurements can be used as a surrogate mar-
ker of atherosclerosis (Figure). Other studies demon-
strated that the relative risks associated with carotid
plaque were similar to or slightly higher than those
observed with increased cIMT. In the past few years,
several groups have shown that carotid plaque pres-
ence or plaque area are more closely related to coro-
nary artery disease and are more strongly predictive of
coronary events.6,22,27–30 In fact, traditional coronary
risk factors explain only 15% to 17% of IMT but
account for 52% of the carotid plaque area, suggesting
that the carotid plaque area is more representative of
atherosclerosis than cIMT.31–33 A very recent report
from the Atherosclerosis Risk In Communities (ARIC)
study demonstrated the ability of carotid ultrasound
data to improve coronary heart disease risk predic-
tion.25 Thus, carotid ultrasound–based cIMT measure-
ment and identification of plaque presence or absence
improves coronary heart disease risk prediction and
should be considered in the intermediate-risk group.
TABLE VI. Simple Linear Regression of Categorical







b P Value b P Value b P Value
Male gender 0.186 .001 0.251 .001 0.134 .123
Smoking 0.044 .446 0.104 .180 0.007 .935
Diabetes 0.138 .017 0.133 .088 0.133 .127
Statin 0.046 .423 0.001 .992 0.094 .282
MS components
Hypertension 0.129 .026 0.113 .148 0.131 .131
WC )0.060 .296 )0.245 .001 0.011 .898
Glucose 0.089 .122 0.116 .138 0.022 .802
Triglycerides 0.065 .260 0.119 .128 )0.110 .205
HDL cholesterol 0.109 .058 0.098 .209 0.089 .304
Abbreviations: cIMT, carotid intima-media thickness; HDL, high-
density lipoprotein; MS, metabolic syndrome; WC, waist
circumference.
TABLE VII. Independent Predictors of cMIT by
Multivariable Analysis
B b t P Value Tolerance VIF
Age 0.008 0.211 3.851 <.001 0.988 1.012
Male sex 0.106 0.159 2.812 .005 0.932 1.073
Log-HDL
cholesterol
)0.315 )0.118 )1.977 .049 0.828 1.208
Log-Insulin 0.124 0.125 2.162 .031 0.889 1.125
Abbreviations: cIMT, carotid intima-media thickness; HDL, high-
density lipoprotein; VIF, variance inflation factor. Final model:
cIMT=0.736+0.008*age (years)+0.106*sex (male=1; female=0))0.315*-
Log-HDL cholesterol+0.124*Log-Insulin.
FIGURE. Carotid and coronary artery disease have similar risk fac-
tors, with identical pathophysiology, and there is a relationship
between the atherosclerotic burden in both sites.45 Thus, carotid ath-
erosclerosis measurements also reflect the degree of coronary and
systemic arterial injury in a given individual. Carotid artery wall analysis
identifies an earlier stage of atherosclerosis by the identification of
non-occlusive plaques and carotid intima-media thickness (cIMT) mea-
surements. Both parameters are independent predictors of future car-
diovascular events, including myocardial infarction, stroke, and cardiac
death5,6,9,19–24 and can be used in clinical practice for cardiovascular
risk assessment. Although cIMT and carotid plaques share a common
pathophysiologic substrate, cIMT might be associated more with
arterial aging and carotid plaques should represent a better surrogate
marker of cardiovascular atherosclerosis.
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These findings support the American Society of Echo-
cardiography’s recommendation of combining cIMT
and carotid plaque data for optimal cardiovascular
risk prediction.8
Intima-media thickening, however, is a feature of
arterial wall aging that is not synonymous with sub-
clinical atherosclerosis, but it is related to it because
the cellular and molecular changes that underline
intima-media thickening have been implicated in the
development and progression of atherosclerosis.
Accordingly, carotid wall thickening is not synony-
mous with atherosclerosis, particularly in the absence
of plaque. It represents the pathophysiologic substrate
that explains why cIMT is a risk factor and a marker
of cardiovascular risk.34,35 This association with age is
clearly evident in our results since age is one of the
main independent predictors of cIMT.
A study demonstrated that women with metaboli-
cally benign overweight ⁄obesity (that fulfills the crite-
ria of clinical obesity by BMI or waist circumference,
but does not have the burden of adiposity-associated
cardiometabolic risk factors) had higher values of
cIMT of the common carotid artery.15 In addition,
they had lower values of cIMT compared with at-risk
overweight ⁄obese women (with associated cardiometa-
bolic risk factors). Thus, metabolic benign over-
weight ⁄obese phenotype had intermediate values of
mean cIMT of the common carotid artery compared
with metabolically benign normal-weight patients and
at-risk overweight ⁄obese individuals. Metabolic benign
patients had similar prevalence of cardiovascular
events in the follow-up than normal-weight individu-
als, and at-risk obese individuals had an elevated car-
diovascular risk. This study suggested MS as an
important predictor of CVD; however, although obes-
ity induced an increase in cIMT, it was not associated
with an increased incidence of cardiovascular events at
follow-up. The cardiovascular events were more
related to cardiovascular risk factor aggregation. In
our study, BMI was not associated with cIMT in the
overall population and both in patients with and with-
out MS. However, abdominal obesity, a different
measurement of obesity and for some authors a mea-
surement that better reflects the obesity-associated
risk, was inversely associated with cIMT in patients
with MS by multivariate analysis. These results, that
are different from the previous study in women, high-
light the gender implications in the obesity-associated
cardiovascular risk. We will discuss below the implica-
tions of abdominal obesity and MS on cardiovascular
risk.
A study by Della-Morte and colleagues36 showed
that MS was not associated with cIMT, but, instead,
was associated with arterial stiffness. On the other
hand, the recently published Ispessimento Medio Inti-
male e Rischio cardiovascolare [media-intima thickness
and cardiovascular risk] (ISMIR) study showed an
association between MS and cIMT.17 The prevalence
of an increased cIMT (defined as common carotid
artery IMT >0.80 mm) was significantly higher in
patients with MS than in patients without it, and
mean cIMT was also significantly higher. The same
was true for the presence of carotid plaques, a marker
of more advanced atherosclerotic lesion. There was a
significant correlation between fasting triglycerides and
cIMT in patients with MS. However, in this study, the
mean levels of fasting triglycerides and total and non–
HDL cholesterol (highly correlated with apolipopro-
tein B and with small dense LDL particles) in patients
with MS were still elevated, despite statin treatment
received by 45% of the patients. Data from previous
studies identified dyslipidemia, either hypercholesterol-
emia or elevated triglycerides levels, as risk factors for
an increased cIMT in the general population. But in
the ISMIR study, in the MS population only triglyce-
rides remained significantly associated with cIMT
value, while total cholesterol and non–HDL choles-
terol failed to reach a significant correlation. The
author’s explanation was that statin treatment, present
in almost half of the subgroups, could alter the typical
lipid profile of these patients, particularly regarding
cholesterol levels and thus modifying the relationship
between plasma cholesterol and cIMT. Our patients
also had a very high rate of statin therapy, and lipid
profile was better than expected, which might have
influenced our results. In fact, only HDL cholesterol
showed some inverse relationship with cIMT. The IS-
MIR study also showed a lack of significant associa-
tion between fasting plasma glucose and cIMT values
in patients with MS, which is supported by the
hypothesis that cIMT seems to be less influenced by
the metabolic risk factors such as diabetes mellitus or
insulin resistance and more an expression of a continu-
ous injury on the arterial intima by hypertension or
lipid deposition.17 However, in our population, insulin
was an independent predictor of cIMT and, in MS
patients, glucose was also a predictor.
These discrepancies might also be related to the fact
that there is a differential effect of cardiovascular risk
factors in different carotid segments that might be
explained by hemodynamic differences in carotid seg-
ments.37–39 Based on these differences, BP might have
a stronger association with the CCA IMT than other
segments, whereas cholesterol would possibly be more
strongly associated with the carotid bulb and ICA
IMT. The Coronary Artery Risk Development in
Young Adults (CARDIA) study analyzed this in young
adults.40 Cardiovascular risk factors explained 26.8%
of the variability for CCA IMT, whereas they
explained only 11.2% of the variability for bulb IMT
and 8.0% of the variability for ICA IMT. Significant
associations were found with age, smoking, LDL cho-
lesterol, hypertension, and male gender. Significant
association of IMT with fasting glucose was seen only
for the CCA IMT. Diabetes was only significantly
associated with bulb IMT. Qualitatively, bulb IMT
appeared to have stronger associations with smoking
and hypertension than for the other segments and was
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the only IMT value significantly associated with diabe-
tes. LDL cholesterol also showed stronger associations
with the ICA IMT than for other levels. Age, gender,
BMI, and systolic BP also had a qualitatively stronger
association with CCA IMT than for other levels. Their
results showed that the mean of the maximum IMT in
the CCA is more strongly associated with cardiovascu-
lar risk factors than IMT measurements made in the
carotid artery bulb or ICA. The association of BP was
stronger in the CCA than for other segments.
The explanation for the differences in the associa-
tion between risk factors and IMT measurements in
different segments is likely linked to bifurcation geom-
etry and differences in hemodynamics for shear stress
and shear stress rates near the lumen of the CCA and
the widened carotid artery bulb.37,38 In the CCA, BP,
shear stress, and shear stress rates are usually strongly
associated with cIMT, especially when no plaque is
present. The carotid bifurcation has a more complex
oscillatory low shear stress that promotes the primary
deposition of LDL cholesterol in the wall. These pro-
cesses ultimately affect the cellular constituents of
the arterial wall. A preponderance of foam cells is
observed in the CCA, whereas more complex and typi-
cal cholesterol-rich plaques are seen at the bifurca-
tion.39 These basic pathophysiologic differences are
likely the explanation for the segmental differences in
the associations between risk factors and IMT.40 The
complex interactions among BP, blood flow, and cho-
lesterol deposition in the arterial wall make it difficult
to isolate individual contributions based only on cross-
sectional associations. Recommended measurement on
the distal centimeter of the CCA might involve a seg-
ment that has a mixed influence of risk factors (transi-
tion segment between CCA and bulb), as shown in
our study. This is particularly important when cIMT
was analyzed as a predictor of stroke. The Cardiovas-
cular Health Study (CHS), the Atherosclerosis Risk in
Communities (ARIC), and the Rotterdam Study
showed an association between common cIMT and
incident stroke.6,9,41 However, more recent studies
showed different results. Both the Tromso study and
the Multi-Ethnic Study of Atherosclerosis (MESA)
showed that common cIMT is associated with incident
stroke in unadjusted analysis, but this association
became nonsignificant after adjustment for risk fac-
tors.42,43 In the MESA study, measurements of cIMT
were made lower in the common carotid and not close
to the carotid bulb.43 Also in the Tromso study, mea-
surements that included the carotid bifurcation were
associated with stroke.42 This confirms the importance
of site measurement.
The inverse association between abdominal obesity
and cIMT was similar to what was observed in the
MESYAS study, but in the context of coronary artery
disease.44 That study showed that the MS factors con-
fer very different intensities of independent risk for
coronary artery disease, from high independent risk of
hypertriglyceridemia to almost no independent effect
of overweight that even appears to be protective,
which seems contradictory. In the absence of obesity,
three other higher-risk criteria are required for the
diagnosis of MS. As a result, there is heterogeneity of
risk among patients with MS, depending on the
particular criteria used for the diagnosis. The CVD
burden derived from obesity is probably mediated by
the appearance of the other known metabolic risk fac-
tors, which cluster more often in the presence of obes-
ity. We can speculate that similar findings might be
obtained for cIMT and this can be an explanation for
our results.
Limitations
Our study is a cross-sectional study, and as such, it is
not possible to establish a causal relationship since no
information from the follow-up was analyzed and
patients underwent only a single evaluation of cIMT.
We did not account for the potential difference
between plaque presence in a single artery vs in multi-
ple arteries. It is possible that plaque presence in
multiple carotid artery segments may be associated
with higher risk. The present scanning protocol for
cIMT measurement focuses primarily on the common
carotid artery due to difficulties in an adequate evalua-
tion of cIMT of the bulb and internal carotid arteries.
However, scanning of the remaining segments of the
carotid arteries for plaques might be important to
avoid missing ‘‘upstream’’ advanced atherosclerosis.
Manual assessment of cIMT is not optimally repro-
ducible. There has been rapid advancement in ultra-
sound technology resulting in greater consistency and
resolution of images. Semiautomated edge-detection
software to measure cIMT has been developed and has
been found to be both accurate and reproducible. This
technology might have yielded different results.
CONCLUSIONS
Nonmodifiable variables (age and male gender) are the
most important determinants of cIMT as well as blood
glucose in MS patients. Abdominal obesity shows a
paradoxical relationship. In patients without MS, age
is the independent predictor and HDL cholesterol is
inversely related.
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